Ginkgo Bioworks Holdings, Inc. (DNA) — Financial statements
Income statement, balance sheet, and cash flow for Ginkgo Bioworks Holdings, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 170↓25.1% | 227↓9.7% | 251↓47.4% | 478↑52.2% | 314 | |
| Cost of Revenue | 32↓18.2% | 39↓28.6% | 54↓73.6% | 204↑57.5% | 130 | |
| Gross Profit | 139↓26.5% | 188↓4.5% | 197↓27.8% | 273↑48.5% | 184 | |
| Operating Expenses | ||||||
| R&D Expenses | 244↓42.5% | 424↓27.0% | 581↓44.8% | 1,053↓8.4% | 1,150 | |
| General & Administrative Expenses | 183↓25.5% | 246↓36.1% | 385↓73.1% | 1,430↑65.7% | 863 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 183↓25.5% | 246↓36.1% | 385↓73.1% | 1,430↑65.7% | 863 | |
| Other Expenses | 27↓65.6% | 78↓18.9% | 96 | 0.00 | 0.00 | |
| Operating Expenses | 454↓39.3% | 748↓29.5% | 1,062↓57.2% | 2,482↑23.3% | 2,013 | |
| Total Costs & Expenses | 485↓38.3% | 787↓29.5% | 1,116↓58.5% | 2,687↑25.4% | 2,142 | |
| Operating Results | ||||||
| Operating Income | -315↑43.7% | -560↑35.2% | -864↑60.9% | -2,209↓20.8% | -1,828 | |
| Depreciation & Amortization | 59↓6.4% | 63↓11.9% | 72↑16.1% | 62↑112.0% | 29 | |
| EBITDA | -255↑47.4% | -484↑41.0% | -821↑60.1% | -2,060↓14.0% | -1,807 | |
| EBIT | -314↑42.7% | -547↑38.7% | -893↑57.9% | -2,121↓15.6% | -1,836 | |
| Interest & Other Income | ||||||
| Net Interest Income | 23↓41.3% | 39↓32.6% | 57↑183.4% | 20↑1412.2% | -2 | |
| Interest Income | 23↓41.4% | 39↓32.5% | 57↑182.4% | 20↑2320.8% | 0.84 | |
| Interest Expense | 0.00↓100.0% | 0.09↑1.1% | 0.09↓12.3% | 0.11↓95.5% | 2 | |
| Non-Operating Income | -2↑86.4% | -12↓143.4% | 28↑132.4% | -88↓1303.8% | 7 | |
| Other Income / Expenses | 2↓86.3% | 12↑142.9% | -29↓132.6% | 88↑1006.8% | -10 | |
| Income Before Tax | -314↑42.7% | -548↑38.7% | -893↑57.9% | -2,121↓15.4% | -1,838 | |
| Income Tax Expense | -0.84↓74.7% | -0.48↓574.6% | -0.07↑99.5% | -15↓915.3% | -1 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -313↑42.8% | -547↑38.7% | -893↑57.6% | -2,106↓14.7% | -1,837 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -313↑42.8% | -547↑38.7% | -893↑57.6% | -2,105↓15.0% | -1,830 | |
| Bottom-Line Net Income | -313↑42.8% | -547↑38.7% | -893↑57.6% | -2,105↓11.5% | -1,889 | |
| EPS (Basic) | -5.64↑46.5% | -10.54↑42.6% | -18.37↑63.4% | -50.15↑6.8% | -53.83 | |
| EPS (Diluted) | -5.64↑46.5% | -10.54↑42.7% | -18.40↑63.3% | -50.20↑9.6% | -55.53 | |
| Weighted Average Shares | 55↑6.9% | 52↑6.9% | 49↑15.7% | 42↑27.2% | 33 | |
| Weighted Average Diluted Shares | 55↑6.9% | 52↑6.8% | 49↑15.8% | 42↑23.5% | 34 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.